A paraneoplastic neuromyelitis optica spectrum disorder associated with a mature B-cell neoplasm

Leukemia Research

Volumn 35, Issue 7, 2011, Pages

  Nakayama Ichiyama, Shoko ^a   Yokote, Taiji ^a   Hiraoka, Nobuya ^a   Iwaki, Kazuki ^a   Takayama, Ayami ^a   Kobayashi, Kichinosuke ^a   Akioka, Toshikazu ^a   Oka, Satoko ^a   Miyoshi, Takuji ^a   Takubo, Takayuki ^a   Tsuji, Motomu ^a   Hanafusa, Toshiaki ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4 ANTIBODY; AUTOANTIBODY; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; PROTEIN ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG; VINCRISTINE;

ADULT; B CELL LYMPHOMA; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; ELECTRON SPIN RESONANCE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERREFLEXIA; LETTER; LIMB WEAKNESS; MULTIPLE CYCLE TREATMENT; MYELOOPTIC NEUROPATHY; PARANEOPLASTIC NEUROMYELITIS OPTICA SPECTRUM DISORDER; PARANEOPLASTIC NEUROPATHY; PARESTHESIA; PRIORITY JOURNAL; TREATMENT RESPONSE;

B-LYMPHOCYTES; FEMALE; HUMANS; MIDDLE AGED; NEUROMYELITIS OPTICA; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; PROGNOSIS;

EID: 79958706504     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.02.019     Document Type: Letter

References (10)

1. Wingerchuk D.M., Lennon V.A., Lucchinetti C.F., Pittock S.J., Weinshenker B.G. The spectrum of neuromyelitis optica. Lancet Neurol 2007, 6:805-815.
2. Hayakawa S., Mori M., Okuta A., et al. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. J Neuroimmunol 2008, 196:181-187.
3. Wingerchuk D.M., Lennon V.A., Pittock S.J., et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66:1485-1489.
4. Sellner J., Boggild M., Clanet M., et al. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol 2010, 17:1019-1032.
5. Nandhagopal R., Al-Asmi A., Gujjar A.R. Neuromyelitis optica: an overview. Postgrad Med J 2010, 86:153-159.
6. World Health Organization classification of tumors of haematopoietic and lymphoid tissues 2008, IARC Press, Lyon. S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele (Eds.).
7. Lennon V.A., Wingerchuk D.M., Kryzer T.J., et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004, 364:2106-2612.
8. Darnell R.B., Posner J.B. Paraneoplastic syndromes involving the nervous system. N Engl J Med 2003, 349:1543-1554.
9. Pittock S.J., Lennon V.A. Aquaporin-4 autoantibodies in a paraneoplastic context. Arch Neurol 2008, 65:629-632.
10. De Santis G., Caniatti L., De Vito A., De Gennaro R., Granieri E., Tola M.R. A possible paraneoplastic neuromyelitis optica associated with lung cancer. Neurol Sci 2009, 30:397-400.